Molly Sauer

Biographic Data

ID7581250
NAMEMolly Sauer
GIVEN NAMESMolly
FAMILY NAMESauer
SIGNATURESAUER M
AFFILIATIONSJohns Hopkins University
ORCID0000-0002-5837-6997
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS0
AUTHOR COUNT7
EDITOR COUNT0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2026
H-INDEX0

  • Pregnant women’s attitudes and intentions toward tuberculosis, malaria, group B streptococcus, and respiratory syncytial virus vaccines in pregnant

    Open AccessRupali J Limaye, Jessica L Schue et al.ARTICLEPLOS Global Public Health2026

    There are numerous infections that can adversely impact a developing fetus, neonates, and pregnant women, and there is limited research related to how specific infections experienced during pregnancy can affect these populations. Tuberculosis (TB), malaria, Group B streptococcus (GBS) and respiratory syncytial virus (RSV) can cause negative outcomes to maternal and neonatal health. For TB and GBS, there are vaccines in various stages of clinical …

  • Contextualizing future maternal RSV vaccination acceptance and trust among pregnant and lactating women in Kenya

    Open AccessMolly Sauer, Berhaun Fesshaye et al.ARTICLEPLOS Global Public Health2025

    Maternal vaccination, or vaccination in pregnancy, offers a critical opportunity to provide protection to pregnant women and simultaneously confer passive immunity to infants in the first months of life, when infections are particularly serious and their immune systems are still developing. Respiratory syncytial virus (RSV) is one such serious infectious disease for newborns, but a newly approved and recommended vaccine for respiratory syncytial …

  • Trust in healthcare providers, information sources, and concerns for new maternal vaccines among pregnant and lactating women in Kenya

    Open AccessJessica L Schue, Berhaun Fesshaye et al.ARTICLEPLOS Global Public Health2025

    New maternal vaccines have the potential to reduce morbidity and mortality for infants from common illnesses that pose the greatest risk in the earliest phase of their life. Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections among infants under six months of age. With the recent approval of a maternal vaccine for RSV, this study aimed to understand decision-making factors among pregnant and lactating women …

  • Understanding Kenyan policymakers’ perspectives about the introduction of new maternal vaccines

    Open AccessRupali J Limaye, Berhaun Fesshaye et al.ARTICLEHealth Policy and Planning2025

    New vaccine policy adoption is a complex process, especially in low-and-middle-income countries, requiring country policymakers to navigate challenges such as competing priorities, human and financial resource constraints, and limited logistical capacity. Since the beginning of the Expanded Programme on Immunization, most new vaccine introductions under this structure have not been aimed at adult populations. The majority of adult vaccines offere…

  • Using antioppressive teaching principles to transform a graduate global health course at Johns Hopkins University

    Open AccessAnna Kalbarczyk, Anushka Aqil et al.ARTICLEBMJ Global Health2023

    Education systems and pedagogical practices in global public health are facing substantive calls for change during the current and ongoing ‘decolonising global health’ movement. Incorporating antioppressive principles into learning communities is one promising approach to decolonising global health education. We sought to transform a four-credit graduate-level global health course at the Johns Hopkins Bloomberg School of Public Health using antio…

  • Closing the pneumococcal conjugate vaccine (PCV) introduction gap

    Open AccessPreetika Banerjee, Jasmine Huber et al.ARTICLEGlobal Health Action2023

    BACKGROUND: Pneumonia remains the leading infectious cause of global childhood deaths, despite the availability of pneumococcal conjugate vaccine (PCV) products and widespread evidence of their safety and efficacy. OBJECTIVE: To map the landscape of countries that are yet to fully include PCV in their National Immunization Programs, we conducted an archetype analysis of country indicators related to barriers and facilitators for PCV decision-maki…

  • Change in full immunization inequalities in Indian children 12–23 months

    Open AccessBrian Wahl, Madhu Gupta et al.ARTICLEBMC Public Health2021

    Immunization coverage and wealth-related equality have improved nationally and in most states over the last decade in India. Targeted, context-specific interventions could help address overall wealth-related full immunization inequalities. Intensified government efforts could help in this regard, particularly in high-focus states where child mortality remains high